Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. MyoKardia, Inc.
  6. Summary
    MYOK   US62857M1053

MYOKARDIA, INC.

(MYOK)
 SummaryChartsNewsRatingsCompany 
Company
MyoKardia, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. The Company is engaged in the business of developing and commercializing therapeutics. The Company has used its precision medicine platform to generate an... 
More about the company
Ratings of MyoKardia, Inc.
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
C-
More Ratings
All news about MYOKARDIA, INC.
02/23Bristol Myers Squibb and Celgene Issue Notices of Redemption and Partial Redemption of ..
AQ
02/04BRISTOL MYERS SQUIBB : Posts 4Q Adjusted Profit, Growth for Eliquis, Opdivo
DJ
01/11Bristol Myers sees up to $25 billion a year of new revenue from current drug pipeline
RE
01/08Avidity Biosciences, Inc. Enters into A Research Collaboration with MyoKardia
CI
2020BRISTOL MYERS SQUIBB : Completes Acquisition of MyoKardia, Strengthening Company's leading..
AQ
2020MyoKardia, Inc. Announces Board Changes
CI
2020MYOKARDIA, INC. : Termination of a Material Definitive Agreement, Completion of Acquisitio..
AQ
2020MYOKARDIA, INC.(NASDAQGM : MYOK) dropped from Russell Small Cap Completeness Index
CI
2020MYOKARDIA, INC.(NASDAQGM : MYOK) dropped from Russell 3000 Growth Index
CI
2020MYOKARDIA, INC.(NASDAQGM : MYOK) dropped from Russell 2000 Index
CI
2020MYOKARDIA, INC.(NASDAQGM : MYOK) dropped from Russell 3000 Index
CI
2020MYOKARDIA, INC.(NASDAQGM : MYOK) dropped from Russell 2500 Index
CI
2020MYOKARDIA, INC.(NASDAQGM : MYOK) dropped from Russell 2500 Growth Index
CI
2020MYOKARDIA, INC.(NASDAQGS : MYOK) dropped from S&P TMI Index
CI
2020MYOKARDIA, INC.(NASDAQGS : MYOK) dropped from S&P Global BMI Index
CI
More news
News in other languages on MYOKARDIA, INC.
02/04US-Pharmakonzern Bristol-Myers wird trotz Quartalsverlusts zuversichtlicher
2020TOUR D’HORIZON DES INDICES : deux indices très ôrotation sectorielleö
2020Des idées d'ETF pour miser sur le retour en grâce des valeurs moyennes
2020AKTIEN NEW YORK SCHLUSS : Trump-Erholung sorgt für starken Wochenauftakt
2020AKTIEN NEW YORK : Gewinne - Nachlassende Unsicherheit dank Trump-Genesungsprozess
More news
Analyst Recommendations on MYOKARDIA, INC.
More recommendations
Chart MYOKARDIA, INC.
Duration : Period :
MyoKardia, Inc. Technical Analysis Chart | MYOK | US62857M1053 | MarketScreener
Managers and Directors
Anastasios E. Gianakakos Chief Executive Officer
Elizabeth Mily President & Director
Robert Scott McDowell Chief Scientific Officer
Jay Edelberg Senior Vice President-Clinical Development
Jeffrey Galik Treasurer, Director & Vice President
Sector and Competitors
1st jan.Capi. (M$)
MYOKARDIA, INC.0.00%11 993
GILEAD SCIENCES, INC.19.29%87 180
BIONTECH SE310.30%67 585
REGENERON PHARMACEUTICALS29.37%65 347
WUXI APPTEC CO., LTD.21.75%63 017
VERTEX PHARMACEUTICALS-13.24%52 137